Point72 Middle East Fze Care Dx, Inc. Transaction History

Point72 Middle East Fze

  • $0
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$4.9 - $12.86 $86,798 - $227,802
-17,714 Reduced 39.41%
27,236 $326,000
Q3 2023

Nov 14, 2023
BUY
$7.0 - $11.26 $314,650 - $506,137
44,950 New
44,950 $314,000
Q1 2023

May 15, 2023
BUY
$8.83 - $17.61 $200,414 - $399,694
22,697 New
22,697 $207,000

Others Institutions Holding CDNA

# of Institutions
218
Shares Held
51.1M
Call Options Held
97.3K
Put Options Held
43.3K
View Full List

About CareDx, Inc.

CDNA Quotes by TradingView
  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email